Veronica Gil
Impact in
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 2
- Oncology 5
- Cancer Cells and Metastasis 2
- Co-authors
- Kevin Petrie (6 shared papers)Arthur Zelent (5 shared papers)Sven Stengel (2 shared papers)Yordan Sbirkov (3 shared papers)Francisco Vega (1 shared paper)Chong Kim (1 shared paper)Jing Zhang (1 shared paper)Lydia Pleotis Howell (1 shared paper)
- Journals
- Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Annals of Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Veronica Gil
11 papers receiving 143 citations
Peers
Comparison fields: 5 of 35
- Oncology 40
- Cancer Research 20
- Genetics 14
- Molecular Biology 89
- Hematology 12
Countries citing papers authored by Veronica Gil
This map shows the geographic impact of Veronica Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Gil more than expected).
Fields of papers citing papers by Veronica Gil
This network shows the impact of papers produced by Veronica Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Gil. The network helps show where Veronica Gil may publish in the future.
Co-authors
The 25 scholars most cited alongside Veronica Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 39 | |
| 2 | 2022 | 24 | |
| 3 | 2015 | 24 | |
| 4 | 2022 | 19 | |
| 5 | 2015 | 16 | |
| 6 | 2019 | 11 | |
| 7 | 2017 | 7 | |
| 8 | 2023 | 2 | |
| 9 | 2007 | 1 | |
| 10 | 2017 | 1 | |
| 11 | 2018 | 1 | |
| 12 | 2022 | 0 |
About Veronica Gil
Veronica Gil is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Genetics, having authored 12 papers that have together received 145 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Protein Degradation and Inhibitors (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Ubiquitin and proteasome pathways (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer Cells and Metastasis (2 papers) and Neurogenesis and neuroplasticity mechanisms (1 paper). The work is most often cited by research in Oncology (40 citations), Cancer Research (20 citations), Genetics (14 citations), Molecular Biology (89 citations) and Hematology (12 citations). Veronica Gil has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Kevin Petrie, Arthur Zelent, Sven Stengel, Yordan Sbirkov, Francisco Vega, Chong Kim, Jing Zhang, Lydia Pleotis Howell, Govind Bhagat and Suzanne Carreira. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.